IL12-engineered human PSMA-CAR T cells for the treatment of advanced prostate cancer
Lupita S. Lopez, Ziyou Cui, Yukiko Yamaguchi, John Paul Murad, Zhiyuan Yang, Ke Zou, Jason Yang, Wen-Chung Chang, Stephen J. Forman, Vivien W.-F. Chan, Saul J. Priceman
This study develops and tests IL12-engineered human PSMA-CAR T cells for advanced prostate cancer, showing improved anti-tumor activity and safety.
Molecular Therapy Advances · Apr 3, 2026Peer-reviewedBioengineering